期刊
INTERNATIONAL UROGYNECOLOGY JOURNAL
卷 30, 期 3, 页码 371-376出版社
SPRINGER LONDON LTD
DOI: 10.1007/s00192-018-3830-0
关键词
Laser; Energy-based devices; Genitourinary syndrome of menopause; Vaginal laxity; Stress urinary incontinence; FDA
This committee opinion reviews the laser-based vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, and stress urinary incontinence. The United States Food and Drug Administration has issued a warning for unsubstantiated advertising and use of energy-based devices. Well-designed case-control studies are required to further investigate the potential benefits, harm, and efficacy of laser therapy in the treatment of genitourinary syndrome of menopause, vaginal laxity, and stress urinary incontinence. The therapeutic advantages of nonsurgical laser-based devices in urogynecology can only be recommended after robust clinical trials have demonstrated their long-term complication profile, safety, and efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据